NFKB1 and arthritic joint disease: We showed here for the first time that oral FPF administration effectively ameliorated arthritis symptoms in a CIA mouse model including joint inflammation, cartilage damage, and bone destruction, concomitant with inhibiting proinflammatory mediators and increasing anti-inflammatory factors and inhibition of NF-κB and MAPK pathways effectively in vivo.